Exploring the Value of <i>BRD9</i> as a Biomarker, Therapeutic Target and Co-Target in Prostate Cancer
Background and aims: Despite recent advances in advanced prostate cancer treatments, clinical biomarkers or treatments for men with such cancers are imperfect. Targeted therapies have shown promise, but there remain fewer actionable targets in prostate cancer than in other cancers. This work aims to...
Main Authors: | Nafisa Barma, Timothy C. Stone, Lina Maria Carmona Echeverria, Susan Heavey |
---|---|
格式: | 文件 |
语言: | English |
出版: |
MDPI AG
2021-11-01
|
丛编: | Biomolecules |
主题: | |
在线阅读: | https://www.mdpi.com/2218-273X/11/12/1794 |
相似书籍
-
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
由: Gerard L Brien, et al.
出版: (2018-11-01) -
FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma
由: Malin Lindén, et al.
出版: (2022-07-01) -
Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular CarcinomaSummary
由: Feng-Kun Zhang, et al.
出版: (2022-01-01) -
Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene
由: Molly E. Heft Neal, et al.
出版: (2021-05-01) -
BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma
由: Qunshan Zhu, et al.
出版: (2023-01-01)